MedPath

Tumor Monitoring Using Thermography During Radiation Therapy

Not Applicable
Conditions
Malignancy
Interventions
Other: Thermography imaging
Registration Number
NCT02776995
Lead Sponsor
Sheba Medical Center
Brief Summary

This research aims to investigate the correlation between tumor temperature difference and biological factors, such as size, metabolism, treatment response, and tumor aggressiveness.

In addition, normal tissue response to adjuvant radiation therapy in treated organs following surgery, will be evaluated.

Detailed Description

During radiation session, the investigators would evaluate the changes that will be detected by thermal imaging and correlate them with visible side effects as well as with known tumor biology factors and skin-tumor distance.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
80
Inclusion Criteria
  • signed informed consent
  • will undergo radiation therapy for palliation or curative intent due to cancer, biopsy proven
Exclusion Criteria
  • not eligible to sign informed consent

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
Patients undergoing radiationThermography imagingIn this study, patients undergoing radiation treatment will undergo thermography imaging during radiation treatment course. Patients will be evaluated with thermography imaging every 5 fraction of radiation, starting prior to the first radiation treatment, periodically, until the end of radiation therapy (a period of several weeks).
Primary Outcome Measures
NameTimeMethod
Measurement of IR : Infra-Red radiation emitted at wavelengths 0.8-1nmBefore the first fraction of radiation and every 5 fraction until the end of radiation therapy, approximately 4-5 weeks.

Mathematical analysis of the thermic image

Secondary Outcome Measures
NameTimeMethod
Dermal side effects during radiation therapy using CTCAE v4.0Before the first fraction of radiation and every 5 fraction until the end of radiation therapy, approximately 4-5 weeks.

Clinical assesment of the side effects by physician.

US/CT scansThe tumor size in cubic cm will be mesured prior to first fraction of radiation, and 2 weeks following the end of radiation session. Time for final evaluation: approximately 6-7 weeks.

The tumor size will be measures to evaluate the efficacy of the radiation treatment.

Trial Locations

Locations (1)

Merav Ben David

🇮🇱

Ramat-Gan, Israel

© Copyright 2025. All Rights Reserved by MedPath